Haemonetics Corp (HAE)
95.76
+0.96
(+1.01%)
USD |
NYSE |
May 17, 16:00
95.76
0.00 (0.00%)
After-Hours: 20:00
Haemonetics Free Cash Flow (Quarterly): 54.40M for March 31, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 54.40M |
| December 31, 2023 | -22.83M |
| September 30, 2023 | 74.47M |
| June 30, 2023 | 9.423M |
| March 31, 2023 | 67.69M |
| December 31, 2022 | 47.57M |
| September 30, 2022 | 51.08M |
| June 30, 2022 | -3.474M |
| March 31, 2022 | 32.94M |
| December 31, 2021 | 35.77M |
| September 30, 2021 | 22.65M |
| June 30, 2021 | -15.60M |
| March 31, 2021 | -10.08M |
| December 31, 2020 | 56.92M |
| September 30, 2020 | 20.82M |
| June 30, 2020 | 4.116M |
| March 31, 2020 | 35.76M |
| December 31, 2019 | 58.89M |
| September 30, 2019 | 20.43M |
| June 30, 2019 | -5.621M |
| March 31, 2019 | 6.922M |
| December 31, 2018 | 28.92M |
| September 30, 2018 | 8.869M |
| June 30, 2018 | -4.392M |
| March 31, 2018 | 38.52M |
| Date | Value |
|---|---|
| December 31, 2017 | 38.82M |
| September 30, 2017 | 43.50M |
| June 30, 2017 | 24.70M |
| March 31, 2017 | 18.96M |
| December 31, 2016 | 36.31M |
| September 30, 2016 | 20.12M |
| June 30, 2016 | 8.216M |
| March 31, 2016 | 24.72M |
| December 31, 2015 | 8.11M |
| September 30, 2015 | 1.627M |
| June 30, 2015 | -15.00M |
| March 31, 2015 | 33.62M |
| December 31, 2014 | -2.765M |
| September 30, 2014 | -2.545M |
| June 30, 2014 | -23.35M |
| March 31, 2014 | 21.54M |
| December 31, 2013 | 29.77M |
| September 30, 2013 | 14.25M |
| June 30, 2013 | 0.31M |
| March 31, 2013 | 15.04M |
| December 31, 2012 | 8.712M |
| September 30, 2012 | 7.023M |
| June 30, 2012 | -7.888M |
| March 31, 2012 | 17.74M |
| December 31, 2011 | 15.69M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-22.83M
Minimum
Dec 2023
74.47M
Maximum
Sep 2023
26.76M
Average
27.79M
Median
Free Cash Flow (Quarterly) Benchmarks
| Stryker Corp | 37.00M |
| ResMed Inc | 378.92M |
| Masimo Corp | 27.00M |
| Insulet Corp | 63.60M |
| InfuSystems Holdings Inc | -1.298M |